uniQure NV (QURE)
6.055
+0.48
(+8.71%)
USD |
NASDAQ |
Nov 05, 16:00
6.055
0.00 (0.00%)
After-Hours: 18:39
uniQure Shareholders Equity (Quarterly): 97.11M for June 30, 2024
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2024 | 97.11M |
| March 31, 2024 | 146.75M |
| December 31, 2023 | 207.67M |
| September 30, 2023 | 268.78M |
| June 30, 2023 | 353.32M |
| March 31, 2023 | 412.77M |
| December 31, 2022 | 476.01M |
| September 30, 2022 | 421.17M |
| June 30, 2022 | 486.49M |
| March 31, 2022 | 546.00M |
| December 31, 2021 | 595.78M |
| September 30, 2021 | 590.76M |
| June 30, 2021 | 633.61M |
| March 31, 2021 | 228.69M |
| December 31, 2020 | 243.90M |
| September 30, 2020 | 227.89M |
| June 30, 2020 | 265.50M |
| March 31, 2020 | 295.15M |
| December 31, 2019 | 323.06M |
| September 30, 2019 | 350.23M |
| June 30, 2019 | 132.06M |
| March 31, 2019 | 157.11M |
| December 31, 2018 | 179.61M |
| Date | Value |
|---|---|
| September 30, 2018 | 199.85M |
| June 30, 2018 | 218.42M |
| March 31, 2018 | 100.26M |
| December 31, 2017 | 89.36M |
| September 30, 2017 | 19.61M |
| June 30, 2017 | 27.29M |
| March 31, 2017 | 45.73M |
| December 31, 2016 | 63.63M |
| September 30, 2016 | 81.20M |
| June 30, 2016 | 94.89M |
| March 31, 2016 | 114.77M |
| December 31, 2015 | 127.93M |
| September 30, 2015 | 146.79M |
| June 30, 2015 | 131.71M |
| March 31, 2015 | 36.57M |
| December 31, 2014 | 52.39M |
| September 30, 2014 | 64.97M |
| June 30, 2014 | 75.46M |
| March 31, 2014 | 85.31M |
| December 31, 2013 | 7.683M |
| September 30, 2013 | 15.28M |
| December 31, 2012 | -0.5925M |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
97.11M
Minimum
Jun 2024
633.61M
Maximum
Jun 2021
358.97M
Average
323.06M
Median
Dec 2019
Shareholders Equity (Quarterly) Benchmarks
| ProQR Therapeutics NV | 35.22M |
| Merus NV | 703.26M |
| argenx SE | -- |
| Pharming Group | 225.79M |
| Pharvaris NV | 356.69M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 730.85M |
| Total Liabilities (Quarterly) | 633.74M |
| Debt to Equity Ratio | 1.056 |
| Current Ratio | 7.357 |
| Net Debt Paydown Yield | 0.07% |